400
Views
0
CrossRef citations to date
0
Altmetric
Case Report

The Unusual Finding of Peripheral Lymphadenopathy Among Confirmed Lassa Fever Patients in Nigeria

ORCID Icon, , , , , , , , , , , & show all
Article: FSO860 | Received 12 Jan 2023, Accepted 17 Apr 2023, Published online: 01 May 2023

References

  • RussierM , PannetierD , BaizeS. Immune responses and Lassa virus infection. Viruses.4(11), 2766–2785 (2012).
  • OgbuO , AjuluchukwuE , UnekeCJ. Lassa fever in West African sub-region: an overview. J Vector Borne Dis.44(1), 1–11 (2007).
  • RichmondJK , BagloleDJ. Lassa fever: epidemiology, clinical features, and social consequences. Br. Med. J.327(7426), 1271–1275 (2003).
  • DanielGB , AustinHD , MamadiC , JamesK , AugustineG , AlphaBet al.Lassa fever in Guinea I. Vector-Borne and Zoonotic Dis.1, 269–281 (2004).
  • LecompteE , Fichet-CalvetE , DaffisS , KoulémouK , SyllaO , KouroumaFet al.Mastomys natalensis and Lassa fever, West Africa. Emerg. Infect. Dis.12(12), 1971–1974 (2006).
  • FrameJD , BaldwinJMJr , GockeDJ , JMT. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am. J. Trop. Med. Hyg.19, 670–676 (1970).
  • ShafferJG , GrantDS , SchieffelinJS , BoisenML , GobaA , HartnettJNet al.Lassa Fever in post-conflict Sierra Leone. PLOS Negl. Trop. Dis.8(3), e2748 (2014).
  • Fisher-HochSP , TomoriO , NasidiA , Perez-OronozGI , FakileY , HutwagnerLet al.Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ311(7009), 857 (1995).
  • WHO. Lassa fever [Internet]. 46, Fact Sheetwww.who.int/news-room/fact-sheets/detail/lassa-fever
  • McCormickJB , KingIJ , WebbPA , JohnsonKM , O'SullivanR , SmithESet al.A case-control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis.155, 445–455 (1987).
  • IloriEA , FuruseY , IpadeolaOBet al.; Nigeria Lassa Fever National Response Team. Epidemiologic and clinical features of Lassa fever outbreak in Nigeria, January 1–May 6, 2018. Emerg. Infect. Dis.25(6), 1066–1074 (2019).
  • OparaNnennaya , NwagbaraUgochinyere , HlongwanaKhumbulani. The COVID-19 impact on the trends in yellow fever and Lassa fever infections in Nigeria. Infect. Dis. Rep.14, 932–941 (2022).
  • MohseniS , ShojaiefardA , KhorgamiZ , AlinejadS , GhorbaniA , GhafouriA. Peripheral lymphadenopathy: approach and diagnostic tools. Iran J Med Sci.39(Suppl. 2), 158–170 (2014).
  • FerrerR. Lymphadenopathy: differential diagnosis and evaluation. Am. Fam. Physician58(6), 1313–1320 (1998).
  • CleggJC , LloydG , SellensM. The pathogenesis of Lassa fever: experimental studies on the origin of lymphocytic infiltration. J. Pathol.. 101(3), 237–244 (1970).
  • GeisbertTW , JahrlingPB. Exotic emerging viral diseases: progress and challenges. Nat. Med.. 10(Suppl. 12), S110–S121 (2004).
  • McCormickJB , KingIJ , WebbPAet al.Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med.. 314(1), 20–26 (1986).